EMERITA RESOURCES CORP (EMO.CA) Fundamental Analysis & Valuation

TSX-V:EMOCA29102L4064

Current stock price

0.335 CAD
+0.02 (+4.69%)
Last:

This EMO.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. EMO.CA Profitability Analysis

1.1 Basic Checks

  • In the past year EMO has reported negative net income.
  • EMO had a negative operating cash flow in the past year.
  • In the past 5 years EMO always reported negative net income.
  • In the past 5 years EMO always reported negative operating cash flow.
EMO.CA Yearly Net Income VS EBIT VS OCF VS FCFEMO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M

1.2 Ratios

  • With a Return On Assets value of -17.59%, EMO perfoms like the industry average, outperforming 54.21% of the companies in the same industry.
  • The Return On Equity of EMO (-20.21%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -17.59%
ROE -20.21%
ROIC N/A
ROA(3y)-24.97%
ROA(5y)-45.86%
ROE(3y)-26.78%
ROE(5y)-49.15%
ROIC(3y)N/A
ROIC(5y)N/A
EMO.CA Yearly ROA, ROE, ROICEMO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400 -600 -800

1.3 Margins

  • EMO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMO.CA Yearly Profit, Operating, Gross MarginsEMO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

5

2. EMO.CA Health Analysis

2.1 Basic Checks

  • EMO has more shares outstanding than it did 1 year ago.
  • EMO has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, EMO has an improved debt to assets ratio.
EMO.CA Yearly Shares OutstandingEMO.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
EMO.CA Yearly Total Debt VS Total AssetsEMO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • EMO has an Altman-Z score of 5.11. This indicates that EMO is financially healthy and has little risk of bankruptcy at the moment.
  • EMO's Altman-Z score of 5.11 is in line compared to the rest of the industry. EMO outperforms 53.33% of its industry peers.
  • EMO has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
  • EMO's Debt to Equity ratio of 0.12 is on the low side compared to the rest of the industry. EMO is outperformed by 65.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 5.11
ROIC/WACCN/A
WACCN/A
EMO.CA Yearly LT Debt VS Equity VS FCFEMO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 11.21 indicates that EMO has no problem at all paying its short term obligations.
  • EMO has a better Current ratio (11.21) than 84.15% of its industry peers.
  • A Quick Ratio of 11.21 indicates that EMO has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 11.21, EMO belongs to the best of the industry, outperforming 84.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 11.21
Quick Ratio 11.21
EMO.CA Yearly Current Assets VS Current LiabilitesEMO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

0

3. EMO.CA Growth Analysis

3.1 Past

  • The earnings per share for EMO have decreased strongly by -22.07% in the last year.
EPS 1Y (TTM)-22.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-116.28%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EMO.CA Yearly Revenue VS EstimatesEMO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2030 2031 100M 200M 300M
EMO.CA Yearly EPS VS EstimatesEMO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2028 2030 2031 0.2 0.4 0.6

0

4. EMO.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • EMO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EMO.CA Price Earnings VS Forward Price EarningsEMO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EMO.CA Per share dataEMO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 0.15 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. EMO.CA Dividend Analysis

5.1 Amount

  • No dividends for EMO!.
Industry RankSector Rank
Dividend Yield 0%

EMO.CA Fundamentals: All Metrics, Ratios and Statistics

EMERITA RESOURCES CORP

TSX-V:EMO (4/14/2026, 7:00:00 PM)

0.335

+0.02 (+4.69%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-26
Earnings (Next)05-26
Inst Owners1.94%
Inst Owner ChangeN/A
Ins Owners6.3%
Ins Owner ChangeN/A
Market Cap99.37M
Revenue(TTM)N/A
Net Income(TTM)-14.12M
Analysts86
Price Target1.68 (401.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-17.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.42
P/tB 1.42
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.24
TBVpS0.24
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -17.59%
ROE -20.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-24.97%
ROA(5y)-45.86%
ROE(3y)-26.78%
ROE(5y)-49.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13077.4%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.21
Quick Ratio 11.21
Altman-Z 5.11
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5247.62%
Cap/Depr(5y)3609.12%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-116.28%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.9%
OCF growth 3YN/A
OCF growth 5YN/A

EMERITA RESOURCES CORP / EMO.CA Fundamental Analysis FAQ

What is the fundamental rating for EMO stock?

ChartMill assigns a fundamental rating of 2 / 10 to EMO.CA.


What is the valuation status of EMERITA RESOURCES CORP (EMO.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to EMERITA RESOURCES CORP (EMO.CA). This can be considered as Overvalued.


Can you provide the profitability details for EMERITA RESOURCES CORP?

EMERITA RESOURCES CORP (EMO.CA) has a profitability rating of 1 / 10.